• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内皮生长因子受体 2 和肿瘤坏死因子受体 1 在乳腺腺癌样本中的表达和细胞因子产生及其与这些恶性肿瘤组织病理学参数的相关性。

VEGF-R2 and TNF-R1 expression and cytokine production by samples of mammary adenocarcinomas and correlations with histopathological parameters of these malignant tumors.

机构信息

1 Novosibirsk State Medical University, Novosibirsk, Russia.

2 Institute of Molecular Biology and Biophysics, Subdivision of Federal Research Center of Fundamental and Translational Medicine, Novosibirsk, Russia.

出版信息

Int J Immunopathol Pharmacol. 2018 Jan-Dec;32:2058738418787990. doi: 10.1177/2058738418787990.

DOI:10.1177/2058738418787990
PMID:29985074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6073826/
Abstract

Currently, the role of cytokines in the tumor progression, including breast cancer, is universally recognized. At the same time, there are still many questions concerning the role of individual cytokines and receptors for cytokines in various morphogenetic processes underlying the tumor progression. The objective of this work was to study cytokine production and vascular endothelial growth factor (VEGF)-R2 and VEGF-R1 expression by mammary adenocarcinoma (MAC) and the correlations with histopathological parameters of malignant tumors. The object of the study was cultured tumor biopsy samples from 47 women aged 43-75 years with invasive ductal carcinoma, which was classified as grade II-III adenocarcinoma. It was shown that the cytokine profiles of the supernatants of MAC samples from patients differ greatly. A correlation between the levels of VEGF-R2 and tumor necrosis factor (TNF)-R1 expression was observed. Correlations were also revealed during analysis of the relations of histopathological MAC indicators with K and K coefficients, which are equal, respectively, to the ratio of expression values of receptors VEGF-R2 and TNF-R1 to the concentrations of the relevant cytokines (VEGF-A and TNF-α) in the culture supernatants of the same MAC samples. A direct correlation was identified between K and some histopathological MAC characteristics: proportion of cells undergoing mitosis or pathological mitosis in MAC and poorly differentiated cells. K directly correlated with the concentration in supernatant interleukin (IL)-18 and interferon (IFN)-γ. K was inversely correlated with the concentration in supernatant of IL-1Ra, IL-8, and granulocyte-macrophage colony-stimulating factor (GM-CSF). The data obtained show that the high-level production of IL-18 and IL-1β by MAC, overexpression of VEGF-R2 in tumor (at relatively low VEGF-A production), and the high level of IFN-γ production are attributed factors contributing to the formation of a population of low-grade cells in the tumor. The factors regulating the population of moderately differentiated cells in the tumor are referred to as IL-1Ra, IL-8, and GM-CSF.

摘要

目前,细胞因子在肿瘤进展中的作用,包括乳腺癌,已得到普遍认可。同时,对于细胞因子的个体作用以及细胞因子受体在肿瘤进展中各种形态发生过程中的作用,仍有许多问题尚未解决。本工作旨在研究乳腺癌的细胞因子产生和血管内皮生长因子(VEGF)-R2 和 VEGF-R1 的表达,并与恶性肿瘤的组织病理学参数相关。研究对象为 47 名年龄 43-75 岁的浸润性导管癌患者的培养肿瘤活检样本,这些患者被归类为 II-III 级腺癌。结果表明,患者 MAC 样本上清液中的细胞因子谱差异很大。观察到 VEGF-R2 水平与肿瘤坏死因子(TNF)-R1 表达之间存在相关性。在分析 MAC 组织病理学指标与 K 和 K'系数的关系时也揭示了相关性,这两个系数分别等于 VEGF-R2 和 TNF-R1 受体表达值与同一 MAC 样本培养上清液中相关细胞因子(VEGF-A 和 TNF-α)浓度的比值。K 与某些 MAC 组织病理学特征之间存在直接相关性:MAC 中细胞有丝分裂或病理性有丝分裂的比例和低分化细胞。K 与上清液中白细胞介素(IL)-18 和干扰素(IFN)-γ的浓度直接相关。K 与上清液中 IL-1Ra、IL-8 和粒细胞-巨噬细胞集落刺激因子(GM-CSF)的浓度呈负相关。所得数据表明,MAC 高水平产生 IL-18 和 IL-1β,肿瘤中 VEGF-R2 过表达(在相对较低的 VEGF-A 产生情况下),以及高水平 IFN-γ 的产生是肿瘤中低级别细胞群形成的促成因素。调节肿瘤中中等分化细胞群的因素被认为是 IL-1Ra、IL-8 和 GM-CSF。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9249/6073826/6835a289ffdc/10.1177_2058738418787990-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9249/6073826/3d24a912727d/10.1177_2058738418787990-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9249/6073826/9a1ee5979e75/10.1177_2058738418787990-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9249/6073826/6835a289ffdc/10.1177_2058738418787990-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9249/6073826/3d24a912727d/10.1177_2058738418787990-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9249/6073826/9a1ee5979e75/10.1177_2058738418787990-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9249/6073826/6835a289ffdc/10.1177_2058738418787990-fig3.jpg

相似文献

1
VEGF-R2 and TNF-R1 expression and cytokine production by samples of mammary adenocarcinomas and correlations with histopathological parameters of these malignant tumors.血管内皮生长因子受体 2 和肿瘤坏死因子受体 1 在乳腺腺癌样本中的表达和细胞因子产生及其与这些恶性肿瘤组织病理学参数的相关性。
Int J Immunopathol Pharmacol. 2018 Jan-Dec;32:2058738418787990. doi: 10.1177/2058738418787990.
2
The Relationship Between Cytokine Production, CSF2RA, and IL1R2 Expression in Mammary Adenocarcinoma, Tumor Histopathological Parameters, and Lymph Node Metastasis.乳腺腺癌中细胞因子产生、CSF2RA 和 IL1R2 表达与肿瘤组织病理学参数及淋巴结转移的关系。
Technol Cancer Res Treat. 2019 Jan-Dec;18:1533033819883626. doi: 10.1177/1533033819883626.
3
Cytokine profiles of tumor supernatants in invasive ductal cancer and fibroadenoma of the breast and its relationship with VEGF-A expression in the tumors.乳腺浸润性导管癌和纤维腺瘤中肿瘤上清液的细胞因子谱及其与肿瘤中VEGF-A表达的关系。
Int J Immunopathol Pharmacol. 2017 Mar;30(1):83-88. doi: 10.1177/0394632016681306. Epub 2017 Jan 24.
4
Cytokine production in mammary adenocarcinoma and its microenvironmental cells in patients with or without metastases in regional lymph nodes.乳腺癌患者中存在转移的区域淋巴结与不存在转移的区域淋巴结中的肿瘤及微环境细胞分泌细胞因子的比较。
Int J Immunopathol Pharmacol. 2017 Sep;30(3):308-314. doi: 10.1177/0394632017720055. Epub 2017 Jul 26.
5
Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.成人骨肉瘤患者细胞因子及细胞因子受体血清水平:与局部肿瘤范围及预后的相关性
J Surg Oncol. 2003 Nov;84(3):151-9. doi: 10.1002/jso.10305.
6
[Influence of the HLDF differentiation factor on the production of cytokines by bio-tissues of breast tissue in its non-malignant diseases and in invasive carcinoma of a non-specific type].[人羊膜来源的间充质干细胞分化因子对乳腺组织非恶性疾病及非特殊类型浸润性癌生物组织细胞因子产生的影响]
Biomed Khim. 2020 Nov;66(6):485-493. doi: 10.18097/PBMC20206606485.
7
Effects of polyclonal activators on cell differentiation and cytokine production of cultured invasive breast carcinoma of no special type, their association with tumour histopathological parameters and lymph node metastasis.多克隆激活剂对非特殊型浸润性乳腺癌细胞分化和细胞因子产生的影响及其与肿瘤组织病理学参数和淋巴结转移的关系。
Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420950580. doi: 10.1177/2058738420950580.
8
Analyzing the relationship between the cytokine profile of invasive breast carcinoma, its histopathological characteristics and metastasis to regional lymph nodes.分析浸润性乳腺癌的细胞因子谱与其组织病理学特征和区域淋巴结转移之间的关系。
Sci Rep. 2021 May 31;11(1):11359. doi: 10.1038/s41598-021-90930-z.
9
Molecular Analysis of Vascular Endothelial Growth Factor (VEGF) Receptors in EUS-guided Samples Obtained from Patients with Pancreatic Adenocarcinoma.从胰腺腺癌患者获取的超声内镜引导样本中血管内皮生长因子(VEGF)受体的分子分析
J Gastrointestin Liver Dis. 2017 Mar;26(1):51-57. doi: 10.15403/jgld.2014.1121.261.eus.
10
Colitogenic role of tumour necrosis factor (TNF) receptors in trinitrobenzene sulphonic acid colitis: TNF-R1 ablation does not affect systemic inflammatory response.肿瘤坏死因子 (TNF) 受体在三硝基苯磺酸结肠炎中的致结肠炎作用:TNF-R1 缺失不影响全身炎症反应。
Clin Exp Immunol. 2011 Sep;165(3):372-82. doi: 10.1111/j.1365-2249.2011.04413.x. Epub 2011 Jun 14.

引用本文的文献

1
Ang-1 and VEGF: central regulators of angiogenesis.血管生成素-1与血管内皮生长因子:血管生成的核心调节因子
Mol Cell Biochem. 2025 Feb;480(2):621-637. doi: 10.1007/s11010-024-05010-3. Epub 2024 Apr 23.
2
Effects of polyclonal activators on cell differentiation and cytokine production of cultured invasive breast carcinoma of no special type, their association with tumour histopathological parameters and lymph node metastasis.多克隆激活剂对非特殊型浸润性乳腺癌细胞分化和细胞因子产生的影响及其与肿瘤组织病理学参数和淋巴结转移的关系。
Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420950580. doi: 10.1177/2058738420950580.
3

本文引用的文献

1
TNF-α sensitizes chemotherapy and radiotherapy against breast cancer cells.肿瘤坏死因子-α使乳腺癌细胞对化疗和放疗敏感。
Cancer Cell Int. 2017 Jan 23;17:13. doi: 10.1186/s12935-017-0382-1. eCollection 2017.
2
Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward?血管内皮生长因子/血管内皮生长因子受体与免疫细胞和癌细胞的关系:惊人还是前沿?
Cancer Biol Med. 2016 Jun;13(2):206-14. doi: 10.20892/j.issn.2095-3941.2015.0070.
3
TNFR1-383 A˃C polymorphism association with clinical manifestations in primary Sjögren's syndrome patients.
The Relationship Between Cytokine Production, CSF2RA, and IL1R2 Expression in Mammary Adenocarcinoma, Tumor Histopathological Parameters, and Lymph Node Metastasis.
乳腺腺癌中细胞因子产生、CSF2RA 和 IL1R2 表达与肿瘤组织病理学参数及淋巴结转移的关系。
Technol Cancer Res Treat. 2019 Jan-Dec;18:1533033819883626. doi: 10.1177/1533033819883626.
肿瘤坏死因子受体1(TNFR1)-383A˃C多态性与原发性干燥综合征患者临床表现的关联
Genet Mol Res. 2016 Jun 15;15(2):gmr4177. doi: 10.4238/gmr.15024177.
4
Cytokines as Mediators of Pain-Related Process in Breast Cancer.细胞因子作为乳腺癌疼痛相关过程的介质
Mediators Inflamm. 2015;2015:129034. doi: 10.1155/2015/129034. Epub 2015 Nov 9.
5
Molecular dynamics and intracellular signaling of the TNF-R1 with the R92Q mutation.具有R92Q突变的TNF-R1的分子动力学和细胞内信号传导
J Neuroimmunol. 2015 Dec 15;289:12-20. doi: 10.1016/j.jneuroim.2015.10.003. Epub 2015 Oct 22.
6
The role of cytokines in breast cancer development and progression.细胞因子在乳腺癌发生发展中的作用。
J Interferon Cytokine Res. 2015 Jan;35(1):1-16. doi: 10.1089/jir.2014.0026. Epub 2014 Jul 28.
7
Mislocalization of death receptors correlates with cellular resistance to their cognate ligands in human breast cancer cells.死亡受体的错误定位与人类乳腺癌细胞对其同源配体的细胞抗性相关。
Oncotarget. 2012 Aug;3(8):833-42. doi: 10.18632/oncotarget.542.
8
Effective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerization.通过结合阻断 VEGFR 配体结合和受体二聚化的抗体来有效抑制血管网络形成。
Cancer Cell. 2010 Dec 14;18(6):630-40. doi: 10.1016/j.ccr.2010.11.001. Epub 2010 Dec 2.
9
Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancers.血管内皮生长因子受体 VEGFR-2 和 VEGFR-3 主要定位于人类原发性实体瘤的脉管系统中。
Clin Cancer Res. 2010 Jul 15;16(14):3548-61. doi: 10.1158/1078-0432.CCR-09-2797. Epub 2010 Jul 6.
10
TRAIL death receptors as tumor suppressors and drug targets.肿瘤坏死因子相关凋亡诱导配体死亡受体作为肿瘤抑制因子和药物靶点。
Cell Cycle. 2008 Jun 1;7(11):1525-8. doi: 10.4161/cc.7.11.5975. Epub 2008 Mar 24.